Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Agentic AI Stocks That Could Deliver 100% Returns

by Global Market Bulletin
April 11, 2026
in Stock Market News
0
Top 10 Agentic AI Stocks That Could Deliver 100% Returns

Top 10 Agentic AI Stocks That Could Deliver 100% Returns

306
SHARES
665
VIEWS
Share on FacebookShare on Twitter

9. UiPath Inc. (NYSE:PATH)

UiPath represents one of the clearest examples of how agentic AI is moving from concept to execution within enterprise environments. Long known for its leadership in robotic process automation, the company is now layering agentic AI capabilities on top of its existing platform, effectively transforming itself into a full-scale automation and orchestration powerhouse.

You might also like

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

The company’s expanded partnership with Deloitte in March 2026 highlights this strategic shift. Together, they introduced Agentic ERP, a solution designed to automate high-friction workflows such as record-to-report and source-to-pay processes. These are not trivial tasks—they sit at the core of enterprise operations, meaning successful automation here can unlock massive efficiency gains and cost savings.

Financial performance reinforces this narrative. UiPath reported quarterly revenue of $481 million and annual recurring revenue of $1.853 billion, alongside full-year revenue of $1.611 billion. Perhaps more importantly, the company achieved its first full year of GAAP operating profitability, generating $57 million in operating income. This transition from growth-at-all-costs to profitable scaling is a critical milestone that institutional investors closely monitor.

Management has emphasized that enterprises are no longer just experimenting with AI—they are deploying it at scale. UiPath’s combination of deterministic automation, agentic AI, and orchestration tools positions it as a foundational layer for enterprise digital transformation, making it a key player in the next phase of AI adoption.

Click next to see the following stock...

Page 2 of 5
Prev123...5Next
Tags: Daily NewsletterFive9 Inc. (NASDAQ:FIVN)Freshworks Inc. (NASDAQ:FRSH)NASDAQ:FIVNNASDAQ:FRSHNASDAQ:VERINYSE:CRMNYSE:PATHSalesforce Inc. (NYSE:CRM)Top 10 Agentic AI Stocks That Could Deliver 100% ReturnsUiPath Inc. (NYSE:PATH)Veritone Inc. (NASDAQ:VERI)Yahoo Finance
Share122Tweet77

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
June 6, 2026
0
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

by Global Market Bulletin
June 6, 2026
0
Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy
  • Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?
  • Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?